Results of phase 3 of the CATIE schizophrenia trial
- 31 January 2009
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 107 (1), 1-12
- https://doi.org/10.1016/j.schres.2008.10.011
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health (N01 MH 90001)
This publication has 14 references indexed in Scilit:
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialThe Lancet, 2008
- Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.2007
- Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine: A CATIE StudyAmerican Journal of Psychiatry, 2007
- Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in SchizophreniaArchives of General Psychiatry, 2006
- Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical AntipsychoticAmerican Journal of Psychiatry, 2006
- Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic TreatmentAmerican Journal of Psychiatry, 2006
- Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant SchizophreniaSchizophrenia Bulletin, 2005
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaThe New England Journal of Medicine, 2005
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003Schizophrenia Bulletin, 2004
- Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized TrialsAmerican Journal of Psychiatry, 2001